The missing middle of sickle therapeutics: Multi-agent therapy, targeting risk, using biomarkers

Robert P. Hebbel, Jacques Elion, Abdullah Kutlar

Research output: Contribution to journal › Comment/debate

Original language	English (US)
Pages (from-to)	1439-1443
Number of pages	5
Journal	American Journal of Hematology
Volume	93
Issue number	12
DOIs	https://doi.org/10.1002/ajh.25289
Publication status	Published - Dec 2018

@article{54e5adca5a67445f85e375845083edac,

title = "The missing middle of sickle therapeutics: Multi-agent therapy, targeting risk, using biomarkers",

author = "Hebbel, {Robert P.} and Jacques Elion and Abdullah Kutlar",

year = "2018",

month = "12",

doi = "10.1002/ajh.25289",

language = "English (US)",

volume = "93",

pages = "1439--1443",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "Wiley-Liss Inc.",

number = "12",

}

TY - JOUR

T1 - The missing middle of sickle therapeutics

T2 - Multi-agent therapy, targeting risk, using biomarkers

AU - Hebbel, Robert P.

AU - Elion, Jacques

AU - Kutlar, Abdullah

PY - 2018/12

Y1 - 2018/12

UR - http://www.scopus.com/inward/record.url?scp=85055515439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055515439&partnerID=8YFLogxK

U2 - 10.1002/ajh.25289

DO - 10.1002/ajh.25289

M3 - Comment/debate

C2 - 30230577

AN - SCOPUS:85055515439

VL - 93

SP - 1439

EP - 1443

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 12

ER -